Tonix Pharmaceuticals Holding (TNXP) EPS (Diluted) (2021 - 2026)

Tonix Pharmaceuticals Holding (TNXP) EPS (Diluted) (2021 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) (Qtr)
1 Oculis Holding AG 66,921.77 Bn 66,921.49 Bn - 0.00
2 Nanobiotix 1,933.35 Bn 1,933.29 Bn - -
3 Akari Therapeutics 1,063.56 Bn 1,063.56 Bn - 0.00
4 BeOne Medicines 468.54 Bn 463.75 Bn 1.35 Bn 0.15
5 Vertex Pharmaceuticals 123.45 Bn 116.20 Bn 2.59 Bn 4.02
6 Regeneron Pharmaceuticals 70.42 Bn 61.67 Bn 3.31 Bn 6.75
7 Belite Bio 63.57 Bn 63.57 Bn - 0.00
8 Argenx Se 55.83 Bn 50.65 Bn 1.41 Bn 7.33
9 Alnylam Pharmaceuticals 37.75 Bn 34.74 Bn 959.66 Mn 1.49
10 Tonix Pharmaceuticals Holding 140.70 Mn 140.70 Mn 5.30 Mn -2.93

Historic Data

Download Data
DateValue
Mar 31, 2026 -2.93
Dec 31, 2025 -5.51
Sep 30, 2025 -3.59
Jun 30, 2025 -3.86
Mar 31, 2025 -2.84
Dec 31, 2024 -30.02
Sep 30, 2024 -22.88
Jun 30, 2024 -1,928.37
Mar 31, 2024 -591.06
Dec 31, 2023 -5,130.89
Sep 30, 2023 -5,840.29
Jun 30, 2023 -8,571.95
Mar 31, 2023 -10,418.24
Dec 31, 2022 -19,073.31
Sep 30, 2022 -13,820.22
Jun 30, 2022 -24,459.82
Mar 31, 2022 -32,564.95
Dec 31, 2021 -51,938.49
Sep 30, 2021 -32,000.00
Jun 30, 2021 -44,948.47